Literature DB >> 1386087

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

E Boerwinkle1, C C Leffert, J Lin, C Lackner, G Chiesa, H H Hobbs.   

Abstract

Plasma lipoprotein(a) [Lp(a)], a low density lipoprotein particle with an attached apolipoprotein(a) [apo(a)], varies widely in concentration between individuals. These concentration differences are heritable and inversely related to the number of kringle 4 repeats in the apo(a) gene. To define the genetic determinants of plasma Lp(a) levels, plasma Lp(a) concentrations and apo(a) genotypes were examined in 48 nuclear Caucasian families. Apo(a) genotypes were determined using a newly developed pulsed-field gel electrophoresis method which distinguished 19 different genotypes at the apo(a) locus. The apo(a) gene itself was found to account for virtually all the genetic variability in plasma Lp(a) levels. This conclusion was reached by analyzing plasma Lp(a) levels in siblings who shared zero, one, or two apo(a) genes that were identical by descent (ibd). Siblings with both apo(a) alleles ibd (n = 72) have strikingly similar plasma Lp(a) levels (r = 0.95), whereas those who shared no apo(a) alleles (n = 52), had dissimilar concentrations (r = -0.23). The apo(a) gene was estimated to be responsible for 91% of the variance of plasma Lp(a) concentration. The number of kringle 4 repeats in the apo(a) gene accounted for 69% of the variation, and yet to be defined cis-acting sequences at the apo(a) locus accounted for the remaining 22% of the inter-individual variation in plasma Lp(a) levels. During the course of these studies we observed the de novo generation of a new apo(a) allele, an event that occurred once in 376 meioses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386087      PMCID: PMC443062          DOI: 10.1172/JCI115855

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

Authors:  K BERG
Journal:  Acta Pathol Microbiol Scand       Date:  1963

2.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.

Authors:  I Oberlé; F Rousseau; D Heitz; C Kretz; D Devys; A Hanauer; J Boué; M F Bertheas; J L Mandel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

3.  Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a].

Authors:  J W Gaubatz; K I Ghanem; J Guevara; M L Nava; W Patsch; J D Morrisett
Journal:  J Lipid Res       Date:  1990-04       Impact factor: 5.922

4.  Unequal crossover generates variation in ubiquitin coding unit number at the human UbC polyubiquitin locus.

Authors:  R T Baker; P G Board
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

5.  Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region.

Authors:  E Boerwinkle; W J Xiong; E Fourest; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  A more powerful robust sib-pair test of linkage for quantitative traits.

Authors:  C I Amos; R C Elston; A F Wilson; J E Bailey-Wilson
Journal:  Genet Epidemiol       Date:  1989       Impact factor: 2.135

7.  Complex segregation analysis of the Lp(a)/pre-beta 1-lipoprotein trait.

Authors:  L Iselius; G Dahlén; U de Faire; T Lundman
Journal:  Clin Genet       Date:  1981-08       Impact factor: 4.438

Review 8.  The mysteries of lipoprotein(a).

Authors:  G Utermann
Journal:  Science       Date:  1989-11-17       Impact factor: 47.728

9.  Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons.

Authors:  J E Hixson; M L Britten; G S Manis; D L Rainwater
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

10.  Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

Authors:  G H Dahlen; J R Guyton; M Attar; J A Farmer; J A Kautz; A M Gotto
Journal:  Circulation       Date:  1986-10       Impact factor: 29.690

View more
  170 in total

1.  Lipoprotein (a) metabolism estimated by nonsteady-state kinetics.

Authors:  K G Parhofer; T Demant; M M Ritter; H C Geiss; M Donner; P Schwandt
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

2.  An application of apo(a) isoforms for the clinical assessment of Lp(a).

Authors:  S Takayama; Y Yasumuro; J h Kim; M Ishikawa; D Tsujino; S Matsuo; Y Harada; S Sugii
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 3.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

4.  Relationship of lipoprotein(a) levels to physical activity and family history of coronary heart disease.

Authors:  S Martín; R Elosua; M I Covas; M Pavesi; J Vila; J Marrugat
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

Review 5.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

Review 6.  Searching for the mountains of the moon: genome scans for atherosclerosis.

Authors:  Michael A Province
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

7.  A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription.

Authors:  Sarita Negi; Saurabh K Singh; Nirupma Pati; Vikas Handa; Ruchi Chauhan; Uttam Pati
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

8.  Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.

Authors:  Nastaran Faghihnia; Sotirios Tsimikas; Elizabeth R Miller; Joseph L Witztum; Ronald M Krauss
Journal:  J Lipid Res       Date:  2010-08-16       Impact factor: 5.922

Review 9.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Authors:  J Gustav Smith; Robert E Gerszten
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

Review 10.  Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein.

Authors:  Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.